Have a personal or library account? Click to login
Prognostic Biomarkers in Early-Stage B-CLL Patients Cover

Prognostic Biomarkers in Early-Stage B-CLL Patients

Journal of Biomedical and Clinical Research
Volume 10 (2017): Issue 2 (December 2017)
By: Vanya S. Popova,  Svetla O. Blajeva,  Margarita L. Alexandrova,  Tsvetan H. Lukanov,  Silvia Y. Naneva and  Nikolay T. Tzvetkov  
Open Access
|Jun 2018

Authors

Vanya S. Popova

Division of Haematology, Medical University – Pleven, Bulgaria

Svetla O. Blajeva

slavcheva_v@yahoo.com

Department of Clinical Laboratory, Clinical Immunology and Allergology, Medical University – Pleven, Bulgaria

Margarita L. Alexandrova

Department of Physics and Biophysics, Preclinical and Clinical Sciences, Medical University – Pleven, Bulgaria

Tsvetan H. Lukanov

Department of Clinical Laboratory, Clinical Immunology and Allergology, Medical University – Pleven, Bulgaria

Silvia Y. Naneva

Division of Haematology, Medical University – Pleven, Bulgaria

Nikolay T. Tzvetkov

Division of Haematology, Medical University – Pleven, Bulgaria
DOI: https://doi.org/10.1515/jbcr-2017-0022 | Journal eISSN: 1313-9053
Journal RSS Feed
Language: English
Page range: 135 - 139
Submitted on: Nov 24, 2017
|
Accepted on: Feb 27, 2018
|
Published on: Jun 30, 2018
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
microglobulin,
leukemia,
stage,
Rai,
risk
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Ophthalmology,
Public health,
Pharmacy,
Clinical pharmacy

© 2018 Vanya S. Popova, Svetla O. Blajeva, Margarita L. Alexandrova, Tsvetan H. Lukanov, Silvia Y. Naneva, Nikolay T. Tzvetkov, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 10 (2017): Issue 2 (December 2017)Next article